In this study, we found that PZH inhibited the proliferation of CRC cells in vitro, and stalled the xenograft tumor growth in vivo partially through inhibiting IFNGR1-JAK1-STAT3-IRF1 signaling to down-regulate the expression of PD-L1. The gene discussed is STAT3; the disease is colorectal carcinoma.